Literature DB >> 21844060

Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study.

Elizabeth R Unger1, Nancy N Fajman, Elizabeth M Maloney, Juanita Onyekwuluje, David C Swan, Laurie Howard, Consuelo M Beck-Sague, Mary K Sawyer, Rebecca G Girardet, Robert L Sautter, Margaret R Hammerschlag, Carolyn M Black.   

Abstract

OBJECTIVES: To characterize the epidemiology of genital human papillomavirus (HPV) infection in children without previous consensual sexual activity, comparing HPV prevalence by certainty of child sexual abuse (CSA). PATIENTS AND METHODS: Patients presenting for evaluation of CSA in 8 sites in Atlanta, Houston, Harrisburg, and New York City were recruited along with patients presenting for unrelated health visits. CSA certainty was classified as definite, probable, possible, or no evidence following published guidelines and the results of history, physical examination, and laboratory tests. Urine and swabs of external genitalia were tested for HPV using L1 consensus polymerase chain reaction.
RESULTS: The study included 576 participants (89.9% female) aged 6 months to 13 years (mean: 7.9); 534 of whom were evaluated for CSA and 42 for unrelated reasons. Of those evaluated for CSA, 14 had genital warts. One or more HPV types were detected in 11.8% (61 of 517) of participants with adequate samples. HPV detection was more likely among abused participants (definite, probable, or possible) than among participants without evidence of CSA (13.7% and 1.3%, respectively; P < .0001) and increased with certainty of abuse (8.4%, 15.6%, and 14.5% in participants with possible, probable, and definite CSA, respectively; P < .0001). Participants aged 10 years or older had a higher prevalence of HPV (20.6%) than others (5.6%) (P < .0001). CSA, anogenital warts, and age were independently associated with HPV detection.
CONCLUSIONS: HPV detection was associated with CSA and increased with CSA certainty. In this population, genital HPV seemed to behave as a sexually transmitted infection.

Entities:  

Mesh:

Year:  2011        PMID: 21844060     DOI: 10.1542/peds.2010-2247

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.

Authors:  Inge Verdenius; Diane M Harper; George D Harris; R Stephen Griffith; Jeffrey Wall; Laura K Hempstead; Gerard J Malnar; Ruud L M Bekkers
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

3.  A Discussion of High-Risk HPV in a 6-Year-Old Female Survivor of Child Sexual Abuse.

Authors:  Connie D Cao; Lena Merjanian; Joelle Pierre; Adrian Balica
Journal:  Case Rep Obstet Gynecol       Date:  2017-05-23

Review 4.  Towards the eradication of HPV infection through universal specific vaccination.

Authors:  Piergiorgio Crosignani; Antonella De Stefani; Gaetano Maria Fara; Andrea M Isidori; Andrea Lenzi; Carlo Antonio Liverani; Alberto Lombardi; Francesco Saverio Mennini; Giorgio Palu'; Sergio Pecorelli; Andrea P Peracino; Carlo Signorelli; Gian Vincenzo Zuccotti
Journal:  BMC Public Health       Date:  2013-07-11       Impact factor: 3.295

5.  Giant Condyloma Acuminate Due to Human Papillomavirus Type 16 in an Infant Successfully Treated with Topical Imiquimod Therapy.

Authors:  Meltem Dinleyici; Nurhan Saracoglu; Makbule Eren; Ömer Kiliç; Evrim Ciftci; Ener Cagri Dinleyici; Cigdem Sag; Ates Kara
Journal:  Dermatol Reports       Date:  2015-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.